Male contraceptive method and composition
OwnerRonald Zimmermaninventor
Life of this patent
Estimating the term…
Abstract
The present invention relates to a male contaceptive composition suitable for oral administration, wherein the composition comprises a pharmaceutically acceptable, non-toxic cationic salt of an alkyl sulfate.
Claims19
An oral contraceptive composition comprnsing a compound of the formula:
- 28
- wherein X is F or S;
- R is C4-C24 alkyl, C4-C24 alkenyl, C4-C24 alkoxy,
- 29
- R3(OCH2CH2)mO— or
- 30
- R1 is H, C1-C4 alkyl, a pharmaceutically acceptable cation or
- 31
- wherein L is 4 to 4 ;
- R5 is H, C,-C4 alkyl, phenyl or a pharmaceutically acceptable cation, R2 is C4-C24 allyl or C4-C24 alkoxy, n is 0 to 4;
- R3 is C4-C24 alkyl, m is 3 to 10;
- R4 is H, C,-C4 alkyl or COOR6;
- R6 is H or C,-C,3 alkyl;
- and
- Y=0 or nh and a pharmaceutically acceptable carrier suitable for oral delivery:
A contraceptive trnnsdennal patch or implat, wherein said patch or implant comprises a composition comprising a compound of the general formula:
- 39
- wherein X is P or S;
- R5 is C4-C24 alkyl, C4-C24 alkenyl, C4-C24 alkoxy,
- 40
- R3(OCH2CH2)mO— or
- 41
- R1 is H, C1-C4 alkyl, a pharmaceutically acceptable cation
- 42
- wherein L is 4 to 24;
- R5 is H, C1-C4 alkyl, phenyl or a pharmaceutically acceptable cation,
- R2 is C4-C24 alkyl or C4-C24 alkoxy, n is 0 to 4;
- R3 is C4-C24 alkyl, m is 3 to 10;
- R4 is H1- C4 alkyl or COOR6;
- R6 is C1-C13 alkyl;
- and
- Y=O or NH.
A method of inhibiting the capacitation of sperm cells, said method comprising the steps of contacting the sperm cells with a composition comprising a compound of the general formula:
- 43
- wherein X is P or S;
- R is C4-C24 alkyl, C4-C24 alkenyl, C4-C24 alkoxy,
- 44
- R3(OCH2CH2)mO— or
- 45
- R1 is H, C1-C4 alkyl, a pharmaceutically acceptable cation or
- 46
- wherein L is 4 to 24;
- R is H, C1-C4 alkyl, phenyl or a pharmaceutically acceptable cation,
- R2 is C4-C24 alkyl or C4-C4 alkoxy, n is 0 to 4;
- R3 is C4-C24 allyl, m is 3 to 10;
- R4 is H, C1-C4 alkyl or COOR6;
- R is C,-C,3 alkyl;
- and
- Y =0 or NH and a pharmaceutically acceptable carrier.
A method for irubiting conception, comprising
- administering to a male an effective amount of a pharmaceutically acceptable cationic salt of a compound of the general formula:
- 47
- wherein X is P or S;
- R is C4-C24 alkyl, C4-C24 alkenyl, C4-C24 alkoxy,
- 48
- R3(OCH2CH2)mO— or
- 49
- R1 is H, C1-C4 alkyl, a pharmaceutically acceptable cation or
- 50
- wherein L is 4 to 24;
- R5 is H, C1-C4 alkyl, phenyl or a pharmaceutically acceptable cation,
- R2 is C4-C24 alkyl or C4-C24 alkoxy, n is 0 to 4;
- R3 is C4-C24 alkyl, m is 3 to 10;
- R4 is H, C1-C4 alkyl or COOR6;
- R6 is C1-C13 alkyl;
- Y=O or NH.
Dependencies are inferred from the claim text.